AstraZeneca announced an equity investment and clinical collaboration with Summit Therapeutics to advance ADC combinations...

Nurix Therapeutics announced a $7 million milestone achievement under its strategic collaboration with Pfizer

Dong-A ST and Galux entered a research collaboration to develop AI-designed antibodies for ADC therapeutics

Telix and ITM join forces to create a radiopharmaceutical powerhouse

BoomRay enters exclusive global license agreement with Novartis for a novel radioligand therapy asset

Escugen and Sovran expand collaboration to co-develop a novel bispecific ADC

Adagene announced a milestone with Exelixis supporting the advancement of SAFEbody ADC candidates

Cellbion and AHN-GOOK Pharmaceutical announced a collaboration for the joint development of next-generation radiopharmaceuticals

ITM and SpiroChem announced a strategic discovery collaboration to expand ITM’s radiopharmaceutical pipeline